Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

Transactions / Accuratus Lab Services

Thompson Street Capital Partners And Its Portfolio Company, Microbiology Research Associates, Forms A New Partnership Through An Acquisition Of Accuratus Lab Services

Add-on acquisitionannouncedadd-onannounced Sep 7, 2016Fact
What happened
Platform
Microbiology Research Associatesadd-on basis: Thompson Street Capital Partners (TSCP), a private equity firm in St. Louis with $1.5 billion of assets under management, announced today that it has partnered with management and its portfolio company, Microbiology Research Associates (MRA) to acquire Accuratus Lab Services (Accuratus), the leading service provider to the developers, manufacturers, and users of antimicrobial products.
Control
Control
Share acquired
unknown
Industry
unknown
Target location
MN, US
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • Thompson Street Capital Partners (TSCP), a private equity firm in St. Louis with $1.5 billion of assets under management, announced today that it has partnered with management and its portfolio company, Microbiology Research Associates (MRA) to acquire Accuratus Lab Services (Accuratus), the leading
  • Thompson Street Capital Partners (TSCP), a private equity firm in St. Louis with $1.5 billion of assets under management, announced today that it has partnered with management and its portfolio company, Microbiology Research Associates (MRA) to acquire Accuratus Lab Services (Accuratus), the leading
Side not stated
  • Fran McAteerManagementconfirmed
    Fran McAteer, President of MRA said, “MRA is pleased to partner with Accuratus and looks forward to expanding and integrating both companies’ services to provide leadership and further our expertise in microbiological contamination control.
  • Alan RothManagementconfirmed
    Alan Roth, General Manager of Accuratus, said, “This acquisition strengthens our ability to service our core antimicrobial customers while further diversifying our business service offerings to include new industries.
  • Accuratus Lab ServicesTargetconfirmed
    Thompson Street Capital Partners (TSCP), a private equity firm in St. Louis with $1.5 billion of assets under management, announced today that it has partnered with management and its portfolio company, Microbiology Research Associates (MRA) to acquire Accuratus Lab Services (Accuratus), the leading
Evidence
Thompson Street Capital Partners (TSCP), a private equity firm in St. Louis with $1.5 billion of assets under management, announced today that it has partnered with management and its portfolio company, Microbiology Research Associates (MRA) to acquire Accuratus Lab Services (Accuratus), the leading service provider to the developers, manufacturers, and users of antimicrobial products.
Thompson Street Capital Partners And Its Portfolio Company, Microbiology Research Associat | Private Equity Intelligence | DFX